Recombinant Human TNF-α (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
Tumor necrosis factor-α, Cachectin, Necrosin, Macrophage cytotoxic factor (MCF), Differentiation inducing factor (DIF), TNFSF2
TNFa_Human_Recombinant_Protein_BA_101612
Human TNF-α cytotoxicity on L929 cells.
  • TNFa_Human_Recombinant_Protein_BA_101612
    Human TNF-α cytotoxicity on L929 cells.
Cat # Size Price Quantity Check Availability
570102 10 µg $147.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
570104 50 µg $235.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
570106 100 µg $422.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
570108 500 µg $938.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

TNF-α is released from macrophages, monocytes, neutrophils, T-cells (principally CD4+), NK-cells and many transformed cell lines. Soluble homotrimeric TNF-α is released from cells by proteolysis of the integral membrane precursor form of TNF-α. TNF-α binding to some TNF-α receptors induces apoptosis and depending on cell type, receptor expression, and signal transduction status can induce other responses. TNF-α is involved in the inflammatory response.

Technical data sheet

Product Details

Source
Human TNF-α, amino acids Val77-Leu233 (Accession# NM_000594), was expressed in E. coli.
Molecular Mass
The 157 amino acid recombinant protein has a predicted molecular mass of 17,352 Da. The DTT-reduced protein and non-reduced protein migrate at approximately 16kDa by SDS-PAGE. The N-terminal amino acid is Val.
Purity
Purity is >98%, as determined by Coomassie stained SDS-PAGE.
Formulation
0.22 µm filtered protein solution is in 10mM NaH2PO4, 150mM NaCl, pH 7.2.
Endotoxin Level
Endotoxin level is <0.1 EU/µg (<0.01ng/µg) protein as determined by the LAL method.
Concentration
10 and 50 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
The ED50 = 0.01 - 0.085 ng/mL as determined by the dose-dependent cytotoxicity of L929 cells stimulated with actinomycin D.

The specific activity of recombinant human TNF-α is approximately 5.35 x 104 IU/µg when compared against the 3rd WHO International Standard for Human TNF-α (NIBSC code: 12/154).

For more information on specific activity, please visit the Recombinant Protein Unit Conversions page.
Application

Bioassay

Recommended Usage

Use when high specific biological activity is required.

Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Application References

(PubMed link indicates BioLegend citation)
  1. Chen AR, et al. 1985. J. Immunol. 135:3978.
Product Citations
  1. Mavrikaki M, et al. 2022. Nat Aging. 2:1130. PubMed
  2. Gao J, et al. 2023. Pharmaceutics. 15:. PubMed
  3. Orzalli MH, et al. 2021. Immunity. 54:1447. PubMed
  4. Zieman AG, et al. 2019. Hum Mol Genet. 28:2255. PubMed
  5. Srivastava C, et al. 2020. BMC Cancer. 20:62. PubMed
  6. Kolbrink B, et al. 2022. Biochem J. 479:259. PubMed
  7. Zhang H, et al. 2020. Front Cell Dev Biol. 8:205. PubMed
  8. Orzalli MH, et al. 2018. Mol Cell. 71:825. PubMed
  9. Fisher AL, et al. 2021. Nat Commun. 12:4026. PubMed
  10. Chang AY, et al. 2021. J Biol Chem. 297:101277. PubMed
  11. Huh JY, et al. 2020. Cell Metab. 32:1012. PubMed
  12. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  13. Zhichao Fan et al. 2019. Cell reports. 26(1):119-130 . PubMed
  14. Guo J, et al. 2019. Cancer Immunol Res. 1.349305556. PubMed
  15. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  16. Harth S, et al. 2019. MAbs. 11:178. PubMed
  17. de Oliveira Mann CC, et al. 2019. Cell Rep. 27:1165. PubMed
  18. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  19. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  20. Molnár T, et al. 2021. FEBS J. Online ahead of prin. PubMed
  21. Akaki K, et al. 2021. Elife. 10:. PubMed
  22. Fisher AL, et al. 2021. J Biol Chem. 297:101156. PubMed
  23. Fan Z, et al. 2020. STAR Protoc. 1:100012. PubMed
  24. Mori L, et al. 2020. J Virol. . PubMed
  25. Riebeling T, et al. 2020. Cell Death Differ. . PubMed
  26. VanDussen KL, et al. 2019. Stem Cell Res. 37:101430. PubMed
  27. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  28. Tonnus W, et al. 2022. Cell Death Dis. 13:236. PubMed
  29. Anderson NR, et al. 2019. Cell Adh Migr. 13:163. PubMed

Antigen Details

Structure
TNF superfamily; homotrimer
Bioactivity
Paracrine/endocrine mediator of inflammatory and immune functions; selectively cytotoxic for transformed cells; endothelial cell alterations; chemoattractant
Cell Sources
Activated monocytes, neutrophils, macrophages, T cells, B cells, NK cells, LAK cells
Cell Targets
Monocytes, neutrophils, macrophages, T cells, fibroblasts, endothelial cells, osteoclasts, adipocytes, astroglia, microglia
Receptors
TNFRSF1A (TNF-R1, CD120a, TNFR-p60 Type β, p55); TNFRSF1B (TNF-R2, CD120b, TNFR-p80 Type A, p75)
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Molecular Family
Cytokines/Chemokines
Antigen References

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Beutler B, et al. 1988. Annu. Rev. Biochem. 57:505.
3. Beutler B, et al. 1989. Annu. Rev. Immunol. 7:625.
4. Tracey K, et al. 1993. Crit. Care Med. 21:S415.

Regulation
Type II integral membrane protein processed by TACE for secretion; upregulated by interferons, IL-2, GM-CSF, substance P, bradykinin, PAF, immune complexes, cyclooxygenase; downregulated by IL-6, TGF-β, vitamin D3, prostaglandin E2, PAF antagonists
Gene ID
7124 View all products for this Gene ID
UniProt
View information about TNF-alpha on UniProt.org
Go To Top Version: 6    Revision Date: 09/30/2020

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login/Register
Forgot your password? Reset Password
Request an Account